Search research articles
Contact Us
Filters
Showing results (131-140 of 337) with videos related to
Page
of 34
Sort By:
AIDS Research and Human Retroviruses
|
November 12, 2014
Factors associated with daily tenofovir exposure in Thai subjects taking combination antiretroviral therapy
Stephen J Kerr, Baralee Punyawudho, Narukjaporn Thammajaruk, et al.
British Journal of Clinical Pharmacology
|
July 12, 2020
Association between healthcare practitioners' beliefs about statins and patients' beliefs and adherence
Victor J B Huiskes, Cornelia H M van den Ende, Liset van Dijk, et al.
Clinical Pharmacokinetics
|
April 4, 2024
Relative Bioavailability of Dolutegravir (DTG) and Emtricitabine/Tenofovir Alafenamide Fumarate (F/TAF) Administered as Paediatric Tablet Formulations in Healthy Volunteers
Lisanne A H Bevers, Anne E M Kamphuis, L C Wendy van der Wekken-Pas, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
June 20, 2017
Efficacy and safety of a once-daily single-tablet regimen of tenofovir, lamivudine, and efavirenz assessed at 144 weeks among antiretroviral-naïve and experienced HIV-1-infected Thai adults
Anchalee Avihingsanon, Wirach Maek-A-Nantawat, Sivaporn Gatechompol, et al.
Cancer Chemotherapy and Pharmacology
|
September 14, 2019
A prospective phase I multicentre randomized cross-over pharmacokinetic study to determine the effect of food on abiraterone pharmacokinetics
Floor J E Lubberman, Guillemette E Benoist, Winald Gerritsen, et al.
Current Opinion in Pharmacology
|
July 29, 2015
Drug-interactions of azole antifungals with selected immunosuppressants in transplant patients: strategies for optimal management in clinical practice
Vincent J C Lempers, Lisa C Martial, Michiel F Schreuder, et al.
The Journal of Antimicrobial Chemotherapy
|
April 6, 2006
The use of pharmacokinetically guided indinavir dose reductions in the management of indinavir-associated renal toxicity
Mark A Boyd, Umaporn Siangphoe, Kiat Ruxrungtham, et al.
British Journal of Clinical Pharmacology
|
September 8, 2017
Drug-drug interaction potential in men treated with enzalutamide: Mind the gap
Guillemette Emma Benoist, Inge M van Oort, Stella Smeenk, et al.
Antimicrobial Agents and Chemotherapy
|
January 19, 2012
Pharmacokinetics of and short-term virologic response to low-dose 400-milligram once-daily raltegravir maintenance therapy
Jintanat Ananworanich, Meena Gorowara, Anchalee Avihingsanon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 20, 2010
The bilirubin-increasing drug atazanavir improves endothelial function in patients with type 2 diabetes mellitus
Douwe Dekker, Mirrin J Dorresteijn, Margot Pijnenburg, et al.
Page
of 34
Search research articles
Search
Showing results (131-140 of 337) with videos related to
Sort By:
Page
of 34
AIDS Research and Human Retroviruses
|
November 12, 2014
Factors associated with daily tenofovir exposure in Thai subjects taking combination antiretroviral therapy
Stephen J Kerr, Baralee Punyawudho, Narukjaporn Thammajaruk, et al.
British Journal of Clinical Pharmacology
|
July 12, 2020
Association between healthcare practitioners' beliefs about statins and patients' beliefs and adherence
Victor J B Huiskes, Cornelia H M van den Ende, Liset van Dijk, et al.
Clinical Pharmacokinetics
|
April 4, 2024
Relative Bioavailability of Dolutegravir (DTG) and Emtricitabine/Tenofovir Alafenamide Fumarate (F/TAF) Administered as Paediatric Tablet Formulations in Healthy Volunteers
Lisanne A H Bevers, Anne E M Kamphuis, L C Wendy van der Wekken-Pas, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
June 20, 2017
Efficacy and safety of a once-daily single-tablet regimen of tenofovir, lamivudine, and efavirenz assessed at 144 weeks among antiretroviral-naïve and experienced HIV-1-infected Thai adults
Anchalee Avihingsanon, Wirach Maek-A-Nantawat, Sivaporn Gatechompol, et al.
Cancer Chemotherapy and Pharmacology
|
September 14, 2019
A prospective phase I multicentre randomized cross-over pharmacokinetic study to determine the effect of food on abiraterone pharmacokinetics
Floor J E Lubberman, Guillemette E Benoist, Winald Gerritsen, et al.
Current Opinion in Pharmacology
|
July 29, 2015
Drug-interactions of azole antifungals with selected immunosuppressants in transplant patients: strategies for optimal management in clinical practice
Vincent J C Lempers, Lisa C Martial, Michiel F Schreuder, et al.
The Journal of Antimicrobial Chemotherapy
|
April 6, 2006
The use of pharmacokinetically guided indinavir dose reductions in the management of indinavir-associated renal toxicity
Mark A Boyd, Umaporn Siangphoe, Kiat Ruxrungtham, et al.
British Journal of Clinical Pharmacology
|
September 8, 2017
Drug-drug interaction potential in men treated with enzalutamide: Mind the gap
Guillemette Emma Benoist, Inge M van Oort, Stella Smeenk, et al.
Antimicrobial Agents and Chemotherapy
|
January 19, 2012
Pharmacokinetics of and short-term virologic response to low-dose 400-milligram once-daily raltegravir maintenance therapy
Jintanat Ananworanich, Meena Gorowara, Anchalee Avihingsanon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 20, 2010
The bilirubin-increasing drug atazanavir improves endothelial function in patients with type 2 diabetes mellitus
Douwe Dekker, Mirrin J Dorresteijn, Margot Pijnenburg, et al.
Page
of 34